Clinical Trial Update: DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition [Phase 2, Phase 3]

View source ↗

Summary

The update notes ongoing recruitment for the DETERMINE trial Arm 02 investigating atezolizumab in adults and pediatric/young adult patients with cancers charact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms
• Endometrial Neoplasms
• Lymphoproliferative Disorders
• Melanoma
• Solid Tumors

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Cancer Research UK | Conditions: Malignancy, Malignant Neoplasm | Phase 2, Phase 3 | Status: RECRUITING